Involvement of MMPs in the outward remodeling of collateral mesenteric arteries  by Haas, T.L. et al.
JOURNAL OF VASCULAR SURGERY
April 2008894 Abstractsbe convinced that helping their child maintain appropriate weight is vitally
important to decrease adverse health effects in adulthood.
Prevention of perioperative thromboembolism in patients with atrial
fibrillation
Beldi G, Beng L, Siegel G, Fisch-Knaden S, et al. Brit J Surg 2007;94:
1351-5.
Conclusion: Compared with postoperative anticoagulation with low-
molecular-weight heparin (LMWH), postoperative anticoagulation with
therapeutic unfractionated heparin (UFH) in patients receiving long-term
anticoagulation is associated with an increased risk of bleeding and does not
reduce the risk of thromboembolism.
Summary: This was a retrospective study designed to test the safety
and efficacy of two methods of prophylaxis for perioperative thromboem-
bolism in patients with atrial fibrillation (AF), which was present in 1.9% of
patients undergoing 14,801 operative procedures. Patients with AF who
were not receiving oral anticoagulation (n  146) were placed on the
LMWHnadroparin before and after surgery (40U/kg). Those patients with
AF who were on anticoagulation before surgery (n  136) were placed on
intravenous UFH postoperatively at a dose to maintain therapeutic levels.
Arterial or venous thromboembolism occurring in the perioperative
period was independent of pre-existing risk factors. Atrial or venous throm-
boembolism occurred in 4.6% of patients, without significant differences
between the perioperative use of LMWH or UFH (P  .78). Thromboem-
bolism was significantly associated with increased perioperative mortality
(odds ratio, 9.5; 95% confidence interval, 2.5-35.8, P  .001). Postopera-
tive bleeding occurred in 4.8% of patients treated with LMWH and in 17.6%
of patients treated with UFH (P  .001).
Comment: Patients on long-term anticoagulation for AF often must
have anticoagulation interrupted for an operative procedure. During this
time, anticoagulation is generally “bridged” with heparin until vitamin K
antagonists can be restarted. The study is important in that it indicates this
“bridging” of anticoagulation is probably best performed with LMWH,
rather than UFH. Although this was a study of general surgical patients, it is
likely that differences may be even more dramatic in patients undergoing
vascular surgery.
Preoperative cerebral hemodynamic impairment and reactive oxygen
species produced during carotid endarterectomy correlate with devel-
opment of postoperative cerebral hyperperfusion
Suga Y, Ogasawara K, Saito H, et al. Stroke 2007;38:2712-2717.
Conclusion: Reactive oxygen species, which are produced during
carotid endarterectomy (CEA), and preoperative cerebral hemodynamic
impairment correlate with development of cerebral hyperperfusion after
CEA.
Summary: The authors sought to determine the relationship between
production of reactive oxygen species and preoperative cerebral hemody-
namic impairment with postoperative cerebral hyperperfusion in CEA pa-
tients. Malondialdehyde-modified low-density lipoprotein (MDA-LDL) is a
marker of oxidative damage that can bemeasured in serum samples. Cerebral
hemodynamic impairment can be measured using single-photon emission
computed tomography (SPECT) to assess cerebral blood flow and cerebro-
vascular reactivity with acetazolamide. In this study, 90 patients who under-
went carotid endarterectomy for ipsilateral internal carotid artery stenosis
70% were assessed with MDA-LDL levels, as well as preoperative SPECT.
Hyperperfusion was defined as a cerebral blood flow increase of 100%
compared with preoperative values.
After CEA, hyperperfusion was documented by increased cerebral
blood flow in 12 patients (13%). Logistic regression analysis determined that
reduced preoperative cerebrovascular reactivity (95% confidence interval,
1.053-1.453; P  .0097) and an increase in MDA-LDL after internal
carotid artery clamping (95% confidence interval, 0.862-0.980; P  .0098)
were associated with development of postoperative cerebral hyperperfusion.
Of the 11 patients with reduced preoperative cerebrovascular reactivity and
increased MDA-LDL after internal carotid artery clamping, post-CEA hy-
perperfusion developed in 10, and two of these had cerebral hyperperfusion
syndrome.
Comment: It is known post-CEA hyperperfusion syndrome correlates
with reduced preoperative cerebrovascular reactivity. However, hyperperfu-
sion syndrome does not develop in all patients with reduced preoperative
cerebrovascular reactivity (52% in this study). The addition of MDA-LDL
levels to the preoperative assessment of cerebral blood flow in patients at risk
for post-CEA hyperperfusion syndrome may help more precisely identify
patients at risk for postoperative CEA hyperperfusion syndrome.Involvement of MMPs in the outward remodeling of collateral mesen-
teric arteries
Haas TL, Doyle JL, Distasi MR, et al. Am J Physiol Heart Circ Physiol
2007;293:H2429-37.
Conclusion: Matrix metalloproteinase (MMP) activity is essential to
the remodeling process that leads to luminal expansion associated with
collateral vessel enlargement.
Summary: Shear stress is important in collateral enlargement. Eleva-
tions in shear stress within resistance or conduit arteries result in luminal
expansion. The result is normalization of shear stress and maintenance of
flow to the downstream vasculature. This process involves remodeling of the
extracellular matrix and cellular proliferation; however, specific cellular
events leading to these events are poorly understood. It is known thatMMPs
contribute to the remodeling of the extracellular matrix in vein grafts and
conduit vessels exposed to high flow rates. This study sought to evaluate the
role of MMPs in remodeling of small collateral arteries exposed to increases
in shear stress.
The authors used an established model of outward remodeling of
mesenteric collateral arteries that utilizes ileal arteries of maleWistar rats that
are surgically ligated to produce a collateral-dependent region. They sought
to determine whether MMPs were up-regulated during remodeling and to
test whether MMP activity was required for luminal expansion. After 2 to 7
days, arteries were harvested andMMP9 andMMP2 levels determined using
standard gelatin zymography and immunostaining. At 4 days, membrane
type 1 MMP (MT1-MMP) andMMP2, but not MMP9, protein levels were
elevated in collateral arteries. The elevated MMP proteins, along with their
respective transcriptional activators, were predominately localized to the
smooth muscle layer of the collateral arteries. Doxycycline, a general MMP
inhibitor, prevented luminal expansion of collateral arteries but did not
affect medial growth responses or endothelial cell proliferation.
Comment: This study may serve as the basis of a new approach to
improving distal circulation in situations where the primary conduit arteries
are stenosed or occluded. Perhaps enlargement of collateral vessels through
an MMP mechanism can serve as an alternative to angiogenesis in patients
with severe intermittent claudication or critical limb ischemia.
Increased mortality, postoperative morbidity, and cost after red blood
cell transfusion in patients having cardiac surgery
Murphy GJ, Reeves BC, Rogers CA, et al. Circulation 2007;116:2544-52.
Conclusion: In patients having cardiac surgery, red blood cell (RBC)
transfusion is associated with increased rates of ischemic postoperative
morbidity, infection, and early and late mortality, as well as increased
hospital lengths of stay and hospital costs.
Summary: The authors sought to quantify clinical outcomes and costs
with RBC transfusion in patients having cardiac surgery. Databases for
clinical hematology and blood transfusions were linked with the United
Kingdom population register. Hematocrit information was obtained from
intensive care unit charts. Prespecified primary end points were composite
infection (wound infection, septicemia, or respiratory infection) and isch-
emic outcomes (renal impairment from ischemic injury, myocardial infarc-
tion, or stroke). Resource use, cost, and survival were secondary outcomes.
Regression modeling with adjustment for potential confounding variables
was used to determine associations between transfusion and the primary and
secondary outcomes.
Patients were derived from the Bristol Royal Infirmary database of adult
cardiac surgery patients. This included patients having cardiac surgery from
April 1, 1996, to December 31, 2003. Adjusted odds ratio for ischemic
outcomes (832 of 8518) and for composite infections (737 of 8516) were
3.35 (95% confidence interval [CI], 2.68-4.35) and 3.38 (95% CI 2.60-
4.40) respectively. Relative cost of admission was increased by any transfu-
sion at a rate of 1.4 times for transfusion (95% CI 1.37-1.46), varying from
1.11 for 1 U to 3.35 for 9 U transfused. At any time after operation,
patients with transfusion were less likely to have been discharged from the
hospital (hazard ratio [HR] 0.63; 95% CI, 0.60-0.67) and more likely to
have died (0 to 30 days: HR, 6.69; 95% CI, 3.66-15.1; 31 days to 1 year:
HR, 2.59; 95% CI, 1.68-4.17; 1 year: HR, 1.32; 95% CI, 1.08-1.64).
Comment: Transfusion is known to be strongly associated with infec-
tion. In this study however, transfusion was also strongly associated with
increased hospital costs and poorer long-term prognosis. A most surprising
finding was that ischemic outcomes were made worse by transfusion, incon-
sistent with a widely held belief that RBC transfusion improves tissue
oxygenation. It appears another accepted truth in medicine is once again no
more than a half-truth and probably less than that. In fact, we have a very
poor understanding of the indications for RBC transfusion. These data
certainly imply that we are transfusing too many patients and not only
wasting money but also adversely affecting the patients.
